Poly I:C inhibits cell proliferation and enhances the growth inhibitory effect of paclitaxel in oral sqaumous cell carcinoma

References

• Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783–801.
   PubMed Web of Science ®Google Scholar
• Lee MS, Kim YJ. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 2007;76:447–80.
   PubMed Web of Science ®Google Scholar
• Krieg AM. Toll-like receptor 9 (TLR9) agonists in the treatment of cancer. Oncogene 2008;27:161–7.
   PubMed Web of Science ®Google Scholar
• Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 2007;13:552–9.
   PubMed Web of Science ®Google Scholar
• Killeen SD, Wang JH, Andrews EJ, Redmond HP. Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword? Br J Cancer 2006;95:247–52.
   PubMed Web of Science ®Google Scholar
• Salaun B, Coste I, Rissoan MC, Lebecque SJ, Renno T. TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 2006;176:4894–901.
   PubMed Web of Science ®Google Scholar
• Salaun B, Lebecque S, Matikainen S, Rimoldi D, Romero P. Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 2007;13:4565–74.
   PubMed Web of Science ®Google Scholar
• Pries R, Hogrefe L, Xie L, Frenzel H, Brocks C, Ditz C, Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer. Int J Mol Med 2008;21:209–15.
   PubMed Web of Science ®Google Scholar
• Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB. Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 2006;6:1111–18.
   PubMed Web of Science ®Google Scholar
• Mao L, Hong WK, Papadimitrakopoulou VA. Focus on head and neck cancer. Cancer Cell 2004;5:311–16.
   PubMed Web of Science ®Google Scholar
• Hopper C, Kubler A, Lewis H, Tan IB, Putnam G. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int J Cancer 2004;111:138–46.
   PubMed Web of Science ®Google Scholar
• Park JH, Yoon HE, Jeon DI, Ahn SG, Yoon JH. Activation of TLR2 and TLR5 did not affect tumor progression of an oral squamous cell carcinoma, YD-10B cells. J Oral Pathol Med 2010;39:781–5.
   PubMedGoogle Scholar
• Lacour J, Laplanche A, Malafosse M, Gallot D, Julien M, Rotman N, Polyadenylic-polyuridylic acid as an adjuvant in resectable colorectal carcinoma: a 6 1/2 year follow-up analysis of a multicentric double blind randomized trial. Eur J Surg Oncol 1992;18:599–604.
   PubMedGoogle Scholar
• Laplanche A, Alzieu L, Delozier T, Berlie J, Veyret C, Fargeot P, Polyadenylic-polyuridylic acid plus locoregional radiotherapy versus chemotherapy with CMF in operable breast cancer: a 14 year follow-up analysis of a randomized trial of the Federation Nationale des Centres de Lutte contre le Cancer (FNCLCC). Breast Cancer Res Treat 2000;64:189–91.
   PubMedGoogle Scholar
• Adams M, Navabi H, Croston D, Coleman S, Tabi Z, Clayton A, The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer. Vaccine 2005;23:2374–8.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Wei H, Tian Z. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway. BMC Cancer 2008;8:12.
   PubMed Web of Science ®Google Scholar
• Hasan UA, Trinchieri G, Vlach J. Toll-like receptor signaling stimulates cell cycle entry and progression in fibroblasts. J Biol Chem 2005;280:20620–7.
   PubMed Web of Science ®Google Scholar
• Scarim AL, Arnush M, Blair LA, Concepcion J, Heitmeier MR, Scheuner D, Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis. Am J Pathol 2001;159:273–83.
   PubMedGoogle Scholar
• Robbins MA, Maksumova L, Pocock E, Chantler JK. Nuclear factor-kappaB translocation mediates double-stranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL). Endocrinology 2003;144:4616–25.
   PubMedGoogle Scholar
• Kaiser WJ, Kaufman JL, Offermann MK. IFN-alpha sensitizes human umbilical vein endothelial cells to apoptosis induced by double-stranded RNA. J Immunol 2004;172:1699–710.
   PubMed Web of Science ®Google Scholar
• Taura M, Fukuda R, Suico MA, Eguma A, Koga T, Shuto T, TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis. Cancer Sci 2010;101:1610–17.
   PubMed Web of Science ®Google Scholar